Business · 09/07/2015Updated: 10/17/2026 · 1 min read
FDA Releases Guidance for Meetings with Office of Orphan Products Development
Summary
The Food and Drug Administration (FDA) has released a guidance document titled Meetings with the Office of Orphan Products Development, providing recommendations for requesting and preparing meetings with the FDA's Office of Orphan Products Development (OOPD) on various orphan drug-related topics.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →